GABBR1 and epilepsy: Indeed, the GABA-B receptor is a long-standing therapeutic target for the treatment of epilepsy (Bowery, 2006), and more recently the IP3 receptor was reported to be a target of levetiracetam, one of the most effective anti-epileptic drugs (Nagarkatti et al., 2008).